PLoS Med:WHO严重警告:“超级淋病细菌”正在全球扩散,已接近无药可医

2017-07-15 佚名 DeepTech深科技

性传播疾病正在慢慢变得失控!最近,世界卫生组织在《PLoS Medicine》特刊中提出了很严重的警告,认为随着病菌耐药性的提升,绝大部分的抗生素药物将完全失效,这将导致以淋病为代表的性传染病将变得不可治愈。也正因如此,开发出新型的治疗药物在当下已经变的迫在眉睫。

性传播疾病正在慢慢变得失控!最近,世界卫生组织在《PLoS Medicine》特刊中提出了很严重的警告,认为随着病菌耐药性的提升,绝大部分的抗生素药物将完全失效,这将导致以淋病为代表的性传染病将变得不可治愈。也正因如此,开发出新型的治疗药物在当下已经变的迫在眉睫。


图丨淋病细菌

这一结论并非是危言耸听,世界卫生组织是在梳理分析了全球 77 个国家从 2009 年至 2014 年的数据之后得出的结论。数据显示,调查中 66% 的国家都出现过头孢菌素治疗淋病失效的案例,81% 的国家都出现过阿奇霉素有效性降低的案例。

实际上,这并非世界卫生组织第一次发布类似的警告,在去年 8 月 31 日,它们就发布了一份有关淋病治疗的新指导方针,那是世界卫生组织首次在没有给出可供选择的标准药物的情况下提出的,直接表明淋病正变得越来越难以治愈,即将面临无药可治的窘境。

对此,世界卫生组织人类生殖专家 Teodora Wi 博士就曾表示,诱发淋病的致病细菌似乎变得越来越聪明了,不论使用何种抗生素,这些细菌都会很快就产生抗药性。


图丨世界卫生组织

目前,全球范围内每年的性传染病的感染人数约为 7800 万人。其中,最具代表性的淋病是由淋病奈瑟氏球菌引起的,无论是男性还是女性都有被感染的风险。

一旦染上淋病,患者的生殖器处就会有黄绿色或白色的排出物,小便时会伴随着灼烧的疼痛,同时,也会出现喉咙肿胀等各种不适的感觉。相较而言,淋病对于女性的危害甚至会更大,盆腔炎、不育症、异位妊娠乃至艾滋病感染风险上升等一系列的严重疾病都会接踵而至。


图丨淋病对于女性的危害更大

但与此同时,世界卫生组织也坦言,全球范围内的性传染病的控制状况并不容乐观。一方面,随着广大发展中国家的城市化进程加快,人们的生活水平提高,活动范围也越来越广,而另一方面,安全套的使用意识依旧薄弱,加之检测治疗手段的不足,性传染病的危险不降反升,且正在呈蔓延的趋势。

“这 77 个国家中所发掘的这些病例还只是冰山一角”,Wi 博士坦言。

Wi 博士还强调,尽管缺乏数据,我们仍有充分的理由怀疑,耐药性淋病的发病率确实在上升,不仅是在病发更为普遍的非洲低收入国家。即使是在高收入、医疗发达的国家,淋病的发病率和耐药性也在上升。


图丨美国的淋病染病率

去年,美国疾病控制和预防中心的报告指出,耐阿奇霉素淋病的发病率从 2000 年的 0.6% 上升到 2014 年的 2.5%;耐头孢曲松淋病的发病率从 2000 年的 0.1% 上升到 2011 年的 0.4%,达到最高后又降至 2014 年的 0.2%。但在 2015 年,淋病的发病率增长了 13%,患者约 39.5 万人。

面对抗药性淋病的来势汹汹,法国、西班牙和日本三个高收入国家已经证实了无法完全根治淋病的事实。Wi 博士指出,部分国家已经开始采用高剂量组合药物疗法来阻止淋病的耐药性进一步增强。这一措施固然能短期起效,但从长远来将,即使提高剂量也无济于事。

更为重要的是,如果连高收入国家的淋病耐药性都在不断增强,情况在不断恶化,那么对于低收入、高感染率的国家来说则更加是雪上加霜。“我们需要更加警惕耐药性淋病,用不了几年,不可被治愈的淋病将变得更加普遍。” Wi 博士说。


图丨淋病常见抗生素头孢曲松钠

对于这个可能即将到来的重大威胁,世界卫生组织积极呼吁世界各国提出应对措施,重点放在了改善监测手段、提高公众卫生意识和诊断水平等方面。

同时,新药的研发也在推进之中,但遗憾的是,淋病治疗药物的研发渠道相对空缺,目前只有三种新药处于临床研发阶段:最近完成了III期试验的索利霉素(Solithromycin);已完成了II期试验的 Zoliflodacin;以及也完成了II期试验的Gepotidacin。而且,由于这类药物的短期性和潜在的失效风险,使得大型药厂不愿投入到研发之中。


图丨全球抗生素研究与开发伙伴关系领导人Manica Balasegaram

领导非营利组织全球抗生素研究与开发伙伴关系(GARDP)的 Manica Balasegaram 表示:“为了解决淋病新药物研发的迫切需求,我们必须要抓住现有的机会,在短期内,至少促成一种药物的开发和应用,这样一来,不仅可以解病人的燃眉之急,同时也可以抑制淋病抗药性的疯狂增长。”

但在严峻的现实面前,仿佛任何的举措都会显得力有不逮,加拿大多伦多市公共医疗局(Public Health Ontario)微生物学负责人 Vanessa Allen 就表示:“如果我们不能够减缓细菌耐药性的发展速度,或者不能快速研制出新药,恐怕我们不得不倒退回到前抗生素时代的治疗方法。”


图丨加拿大多伦多市公共医疗局微生物学负责人 Vanessa Allen

而 Allen 口中的前抗生素时代指的是淋病患者需要忍受巨大痛苦的机械干预治疗。这些方法包括通过导尿管将大量碘溶液注入尿道或阴道,或者将病人置于一个温度高达 43 摄氏度的“热箱”里以杀死细菌。

为了避免出现上述的可怕场景,世界卫生组织已经启动了全方位的解决方案,在研发新药之外,又进一步强调了简易、方便的治疗方法的重要性——只有将有效的治疗手段简化成易于推广的解决方案,抗药性淋病的解决才会有希望。

原始出处:

Nicola Low, Nathalie Broutet and Richard Turner. A Collection on the prevention, diagnosis, and treatment of sexually transmitted infections: Call for research papers. PLoS Med, 2017,14(6): e1002333. https://doi.org/10.1371/journal.pmed.1002333

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
    2017-07-17 Vyin.微音

    继续关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
    2017-07-17 Mr.Li先生

    十分危险,应当给予重视

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
    2017-07-17 明天会更好!

    不错的,学习了,谢谢分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
    2017-07-15 为啥子

    堵不如导,一味的研发新型抗生素明显是不可行的……

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
    2017-07-15 中医痴

    不错的,学习了,谢谢分享!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
    2017-07-15 NANNIAN

    物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
    2017-07-15 1dd8c52fm63(暂无匿称)

    继续关注

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=223246, encodeId=efb9223246d7, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/6ea2cf893ed66dcfa878ad4a0aacc81b.jpg, createdBy=089f2014679, createdName=Vyin.微音, createdTime=Mon Jul 17 15:04:16 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223201, encodeId=7f85223201b6, content=十分危险,应当给予重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IibQxuGJg8Nh1KeNMs1nZJeeldYs9olQSmfLFMSmc8OR6afKD5WrY1ktGibkd2ccEG1hMLcfjsTroQ86Z9scbvicQ/132, createdBy=3d661927529, createdName=Mr.Li先生, createdTime=Mon Jul 17 12:38:59 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223148, encodeId=ae472231485a, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Mon Jul 17 09:05:57 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607832, encodeId=e86e160e83208, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 16 23:21:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222687, encodeId=aba022268eba, content=堵不如导,一味的研发新型抗生素明显是不可行的……, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xwU6047w4GQZHmaJMe3cGxCqPS0x43a9R04dN3HrAn5diaR2N4pEwoibqiaiaA3m6ia3g3XbZXadIomlRa5WAvjSUHb/0, createdBy=93aa1715091, createdName=为啥子, createdTime=Sat Jul 15 22:16:52 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222546, encodeId=ab23222546a8, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Sat Jul 15 10:59:25 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222509, encodeId=b40f222509ff, content=物竞天择,适者生存。细菌也在不断筛选抗性个体,研制出了药不是万全之法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/00a667e0aacd4492bb8807e4d1a9cdb0/321ace7571eb430dafcf941d4d8c9be7.jpg, createdBy=a9111960637, createdName=NANNIAN, createdTime=Sat Jul 15 09:36:30 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222505, encodeId=a10322250577, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jul 15 09:30:26 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222491, encodeId=58eb22249148, content=细菌会快速反弹, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sat Jul 15 08:51:12 CST 2017, time=2017-07-15, status=1, ipAttribution=)]
    2017-07-15 lovetcm

    细菌会快速反弹

    0

相关资讯

2012欧洲指南——成人淋病的诊断和治疗发布

淋病是一个全球主要公共卫生问题,在2009版欧洲淋病指南的基础上,2012版指南主要针对淋病的检测和治疗,引入双重抗菌治疗等方面提供最新指导建议。目的是优化淋病的检测,诊断,抗菌治疗以及随访等。全文获取:下载地址:指南下载 (需要扣积分2分, 梅斯医学APP免积分下载)

世卫组织发布新方针:淋病或将无药可治

淋球菌耐药菌株已传播到世界各地。图片来源:CDC 这是又一个由细菌感染的传染病即将面临无药可治窘境的信号。8月31日,世界卫生组织(WHO)发布了一份有关淋病治疗的新指导方针,反映了这种性传播疾病正在变得越来越难以治愈的发人深省的现状。 WHO建议不再使用喹诺酮类药物,这是一种正变得越来越没用的抗生素。并且这也是第一次,该机构在提出应该怎么做的同时却没有给出可供选择的标准药物。

Lancet:B群脑膜炎球菌外膜囊胞疫苗预防淋病的效果。

淋病是一主要的全球性公共健康问题,因耐药性而更加棘手。开发有效的疫苗尚未成功,但监测数据提示B群脑膜炎球菌外膜囊胞疫苗会影响淋病的发病率。研究人员对在新西兰15-30岁人群中脑膜炎球菌外膜囊胞B疫苗(MeNZB)抗淋病的效果进行评估。

Lancet:乙脑疫苗或能对抗超级淋病

一种针对乙型脑膜炎的疫苗或能阻止耐抗生素的超级淋病的扩散。

MMWR:阿奇霉素耐药性的出现让淋病患者怎么办?

淋病是一种由淋病奈瑟球菌引起的泌尿生殖系统的化脓性感染,是常见的性传播疾病之一。临床表现以尿道炎、宫颈炎多见,典型症状是排尿困难、尿频、尿急、尿痛、排出黏液或脓性分泌物等。也可侵犯眼睛、咽部、直肠和盆腔等处以及血行播散性感染引起关节炎、肝周炎、败血症、心内膜炎或脑膜炎等,男女皆可患该病,在美国15-24岁的年轻人发生率较高。CDC预计,美国每年约80万人出现淋病感染,确诊人数超过一半。且不可忽视的

世卫组织:淋病或将无药可治

这是又一个由细菌感染的传染病即将面临无药可治窘境的信号。8月31日,世界卫生组织(WHO)发布了一份有关淋病治疗的新指导方针,反映了这种性传播疾病正在变得越来越难以治愈的发人深省的现状。WHO建议不再使用喹诺酮类药物,这是一种正变得越来越没用的抗生素。并且这也是第一次,该机构在提出应该怎么做的同时却没有给出可供选择的标准药物。据估计,由淋球菌引发的淋病每年在全球约导致7800万人感染。尽管有些人不